Field Reimbursement Manager - New Jersey
Apellis Pharmaceuticals, Inc. | |
life insurance, paid time off, 401(k) | |
United States, Massachusetts, Waltham | |
100 5th Avenue (Show on map) | |
Oct 30, 2024 | |
Position Summary: The Field Reimbursement Manager (FRM) helps minimize access & reimbursement barriers for patients and providers to optimize access to Apellis' Ophthalmology portfolio. Within their geography, the FRM is responsible for addressing access barriers by strategically working with customers and accounts to solve the most complex patient access issues through all facets of the reimbursement cycle. The FRM proactively provides education and support on Apellis reimbursement support programs for retina practices, multi-specialty groups, facilities and their staff. As a member of the front-line field team, they serve as the key contact responsible for reimbursement and access support-related matter. The FRM will provide education and support the integration of account implementation plans for Apellis products within practices and sites of care where applicable. Additionally, the FRM will analyse reimbursement and access issues and, in conjunction with their manager, act as the local access and reimbursement resource for internal Apellis partners in their assigned geography. The FRM will coordinate cross functionally across Corporate Accounts, Patient Services and Field Sales to support patient drug accessibility. Key responsibilities include:
Experience:
Skills, Knowledge & Abilities:
Benefits and Perks: Apellis offers a great benefit package which includes: health insurance with full premium coverage, 401K with company match, paid time off (PTO), long- term disability insurance, life insurance and more! Visit https://apellis.com/careers/ to learn more. Company Background: Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn
EEO Statement: Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law. For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records. Other Duties: Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice. #LI-VC |